Medtronic plc (MDT) operating KPIs
MDTNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends April 24
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 3, 2026Score 19/303% below fair value
$96.54−0.57 (-0.59%)
Close on Oct 30, 2026Market cap $123.49BP/E 23.7Yield 2.94%
Medtronic diabetes Portfolio (Consolidated Segment) — Non-U.S. Developed Organic Growth (Legacy through FY2024Q4, %) (%)
Medtronic Form 8-K Geographic Revenue Tables (FY2016–FY2024)
Latest, FY2024
12.7%
Period ended Apr 30, 2024
Change on a year earlier
-0.8 pts
13.5% in FY2023
History
7 years
Since FY2016
Sources
7
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Diabetes Portfolio (Consolidated Segment) — Non-U.S. Developed Organic Growth (Legacy through FY2024Q4, %) (%) | Year on year | Source |
|---|---|---|---|---|
| FY2024 | Apr 30, 2024 | 12.7% | -0.8 pts | Medtronic SEC 8K_EARNINGS — FY2024Q4 (filed 2024-05-23) ↗ |
| FY2023 | Apr 30, 2023 | 13.5% | +6.8 pts | Medtronic SEC 8K_EARNINGS — FY2023Q4 (filed 2023-05-25) ↗ |
| FY2022 | Apr 30, 2022 | 6.7% | +3.5 pts | Medtronic SEC 8K_EARNINGS — FY2022Q4 (filed 2022-05-26) ↗ |
| FY2021 | Apr 30, 2021 | 3.2% | -10.6 pts | Medtronic SEC 8K_EARNINGS — FY2021Q4 (filed 2021-05-27) ↗ |
| FY2020 | Apr 30, 2020 | 13.8% | – | Medtronic SEC 8K_EARNINGS — FY2020Q4 (filed 2020-05-21) ↗ |
| FY2018 | Apr 30, 2018 | 11.0% | – | Medtronic SEC 8K_EARNINGS — FY2018Q4 (filed 2018-05-24) ↗ |
| FY2016 | Apr 30, 2016 | 79.0% | – | Medtronic SEC 8K_EARNINGS — FY2016Q4 (filed 2016-05-31) ↗ |
Cite this data
StockData. (2026). Medtronic Diabetes Portfolio (Consolidated Segment) — Non-U.S. Developed Organic Growth (Legacy through FY2024Q4, %) (%), annual FY2016–FY2024 [Data set]. Compiled from Medtronic SEC filings and investor materials. https://stockdatahq.com/stocks/mdt/kpis/diab-seg-dev-leg-org
See every metric in the Medtronic KPI table. Data updated Oct 31, 2026.